CH5424802

FOB Price
USD $160.00 / Piece
Place Of Origin
china
Minimum Order
100
Packaging
25kg
Delivery
15 Days
High Purity Small-Molecule Inhibitor API CH5424802
(CAS: 1256580-46-7)

Chemical Information
Quick Details:
Product Name CH5424802
Other Name 9-Ethyl-6,11-dihydro-6,6-dimethyl-8-[4-(4-morpholinyl)-1-piperidinyl]-11-oxo-5H-benzo[b]carbazole-3-carbonitrile;CH5424802;AF-802;CH-5424802/RG-7853;Alectinib (CH5424802);Alectinib;AF-802,RG-7853;9-Ethyl-6,11-dihydro-6,6-dimethyl-8-[4-(4-morpholinyl)-1-piperidinyl]-11-oxo-5H-benzo[b]carbazole-3-carbonitrile Alectinib (CH5424802)
Molecular Formula C30H34N4O2
Molecular Weight 482.62
Storage 3years in -20ºC
Targets ALK (F1174L) ALK ALK (R1275Q) INSR KDR
IC50 1 nM 1.9 nM 3.5 nM
IC50 550 nM 1.4 μM
Appearance White to Off-White Solid
Product Specifications Pharmaceutical Grade
MOQ 100 grams
Payment L/C, T/T, Western Union
Shipment EMS, DHL, FedEx
Origion Hubei,China
Packing Aluminium Foil Bag or as Required
Export Ability Global

Product Description:
CH5424802 is a potent and selective ALK inhibitor. Anaplastic lymphoma kinase (ALK) is a tyrosine kinase that is constitutively activated in certain cancers.
CH5424802 is a potent and selective ALK inhibitor with IC50 of 1.9 nM.Alterations in the anaplastic lymphoma kinase (ALK) gene have been implicated in human cancers. Among these findings, the fusion gene comprising EML4 and ALK has been identified in non-small cell lung cancer (NSCLC) and fusion of ALK to NPM1 has been observed in anaplastic large cell lymphoma (ALCL). The possibility of targeting ALK in human cancer was advanced with the launch of crizotinib for NSCLC in the U.S. in 2011. The development of resistance to crizotinib in tumors, however, has led to the need for second-generation ALK inhibitors. One of these, alectinib hydrochloride, has been found to be an orally active, potent and highly selective ALK inhibitor with activity in ALK-driven tumor models. Alectinib has shown preclinical activity against cancers with ALK gene alterations, including NSCLC cells expressing the EML4-ALK fusion and ALCL cells expressing the NPM-ALK fusion. Alectinib was well tolerated and active in a phase I/II study conducted in Japan in patients with ALK-rearranged advanced NSCLC and in patients with ALK-positive NSCLC who had progressed on crizotinib. Alectinib has been submitted for approval in Japan for the treatment of ALK fusion gene-positive NSCLC and is in phase I/II development for ALK-rearranged NSCLC in the U.S.

Applications/Usage:
CH5424802 is a highly selective and potent anaplastic lymphoma kinase (ALK) inhibitor capable of blocking the resistant gatekeeper mutant, which results in reduced cell growth. CH5424802 have been cl inically evaluated for the treatment of patients with ALK-driven tumors.

FEATURED PRODUCT:
Wuhan Newbio Pharm-tech Co., Ltd.
S# CAS No. Product Name S# CAS No. Product Name
1 86639-52-3 7-Ethyl-10-Hydroxycamptothecin 25 183321-74-6 Erlotinib
2 154229-18-2 Abiraterone Acetate 26 183319-69-9 Erlotinib Hydrochloride
3 50-76-0 Actinomycin D 27 159351-69-6 Everolimus
4 106941-25-7 Adefovir 28 56296-78-7 Fluoxetine Hydrochloride
5 850140-72-6 Afatinib 29 184475-55-6 Gefitinib Hydrochloride
6 330784-47-9 Avanafil 30 136572-09-3 Irinotecan Hydrochloride
TriHydrate
7 319460-85-0 Axitinib 31 1441674-54-9 Ledipasvir(Acetone)
8 1421373-66-1 AZD-9291 (Mesylate) 32 191732-72-6 Lenalidomide
9 123524-52-7 Azelnidipine 33 21672 Methotrexate
10 863031-21-4 Azilsartan Medoxomil 34 76144-81-5 Mildronate
11 179324-69-7 Bortezomib 35 474645-27-7 Monomethyl Auristatin E
12 357336-20-0 Brivaracetam 36 63121-00-6 Oxaliplatin
13 842133-18-0 Canagliflozin 49 33069-62-4 Paclitaxel
14 928672-86-0 Canagliflozin HemiHydrate 37 137281-23-3 Pemetrexed Disodium
15 41575-94-4 Carboplatin 38 53123-88-9 Rapamycin
16 50935-04-1 Carubicin 50 135062-02-1 Repaglinide
17 288383-20-0 Cediranib 39 945667-22-1 Saxagliptin Hydrate
18 15663-27-1 Cisplatin 40 709031-78-7 Saxagliptin Hydrochloride
19 877399-52-5 Crizotinib 41 486460-32-6 Sitagliptin
20 171500-79-1 Dalbavancin 42 654671-77-9 Sitagliptin Phosphate Hydrate
21 114977-28-5 Docetaxel 44 85622-93-1 Temozolomide
22 148408-66-6 Docetaxel TriHydrate 45 477600-75-2 Tofacitinib
23 25316-40-9 Doxorubicin hydrochloride 46 540737-29-9 Tofacitinib Citrate
24 133040-01-4 Eprosartan 47 170791-09-0 Trityl Candesartan Cilexetil

ABOUT DELIVERY:
#1 Products can be sent out within 24 hours after payment.
#2 Secure and discreet shipment.
#3 Various methods for your choice, like DHL/FedEx/SF-express.
​
OUR COMMITMENT:
#1 We are manufacturer with own factory and we sale this product at a best quality and low price.
#2 All product listed is available in stock, please contact the sale for more details.
#3 We have QA&QC department to guarantees the quality, product pass rate can reach 100%.
​
CONTACT US:
Telephone +86-027-87002705
Mobile +86-13277093700
newbiopharmtech
FaceBook Page https://www.facebook.com/newbiopharma/
Facebook Group https://www.facebook.com/groups/1739616069613416/
Website http://www.newbiopharm.com/
Online Store http://biocar.en.made-in-china.com/
​
If you want to source ...
#1 Pharmaceutical raw material,
#2 Oncology drug APIs,
#3 Antibiotics or fine chemicals,

We are a reliable manufacturer and supplier in China.
NEWBIO would like to ...
#1 We foucus on the high purity and high quality;
#2 We provide the raw materials at a good price;
#3 We have the best service and we are always there for you.

Please contact us for more infomation!!!
  • Country: China (Mainland)
  • Business Type:
  • Market:
  • Founded Year:2015
  • Address:
  • Contact:Jason Edwards
*Your name:
*Your Email:
*To:Wuhan Newbio Pharm-tech Co., Ltd.
*Subject:
*Message:
Enter between 20 to 3,000 characters. English only.     Characters : 0 / 3000
*Enter the secure code shown below Mfrbee security Image      Reload Image

submiting now We do inquire for you , please wait ...